Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cabaletta Bio (CABA) stock

Learn how to easily invest in Cabaletta Bio stock.

Cabaletta Bio, Inc
NASDAQ: CABA - USD
BIOTECHNOLOGY
$8.17
-$0.05 (-0.61%)

Cabaletta Bio, Inc is a biotechnology business based in the US. Cabaletta Bio shares (CABA) are listed on the NASDAQ and all prices are listed in US Dollars. Cabaletta Bio employs 35 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Cabaletta Bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CABA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cabaletta Bio stock price (NASDAQ: CABA)

Use our graph to track the performance of CABA stocks over time.

Cabaletta Bio shares at a glance

Information last updated 2021-07-22.
Latest market close$11.34
52-week range$7.05 - $16.38
50-day moving average $8.15
200-day moving average $10.70
Wall St. target price$22.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.94

Buy Cabaletta Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cabaletta Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cabaletta Bio price performance over time

Historical closes compared with the close of $11.34 from 2021-05-28

1 week (2021-07-15) N/A
1 month (2021-06-25) 51.60%
3 months (2021-04-26) 2.53%
6 months (2021-01-22) N/A
1 year (2020-07-22) N/A
2 years (2019-07-22) N/A
3 years (2018-07-22) N/A
5 years (2016-07-22) N/A

Cabaletta Bio financials

Gross profit TTM $0
Return on assets TTM -18.4%
Return on equity TTM -30.26%
Profit margin 0%
Book value $4.26
Market capitalisation $204.9 million

TTM: trailing 12 months

Shorting Cabaletta Bio shares

There are currently 1.4 million Cabaletta Bio shares held short by investors – that's known as Cabaletta Bio's "short interest". This figure is 12.1% down from 1.6 million last month.

There are a few different ways that this level of interest in shorting Cabaletta Bio shares can be evaluated.

Cabaletta Bio's "short interest ratio" (SIR)

Cabaletta Bio's "short interest ratio" (SIR) is the quantity of Cabaletta Bio shares currently shorted divided by the average quantity of Cabaletta Bio shares traded daily (recently around 223044.28104575). Cabaletta Bio's SIR currently stands at 6.12. In other words for every 100,000 Cabaletta Bio shares traded daily on the market, roughly 6120 shares are currently held short.

However Cabaletta Bio's short interest can also be evaluated against the total number of Cabaletta Bio shares, or, against the total number of tradable Cabaletta Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cabaletta Bio's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Cabaletta Bio shares in existence, roughly 50 shares are currently held short) or 0.1297% of the tradable shares (for every 100,000 tradable Cabaletta Bio shares, roughly 130 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cabaletta Bio.

Find out more about how you can short Cabaletta Bio stock.

Cabaletta Bio share dividends

We're not expecting Cabaletta Bio to pay a dividend over the next 12 months.

Cabaletta Bio overview

Cabaletta Bio, Inc. , a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. Cabaletta Bio, Inc. has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California.

Stocks similar to Cabaletta Bio

Frequently asked questions

What percentage of Cabaletta Bio is owned by insiders or institutions?
Currently 4.907% of Cabaletta Bio shares are held by insiders and 65.739% by institutions.
How many people work for Cabaletta Bio?
Latest data suggests 35 work at Cabaletta Bio.
When does the fiscal year end for Cabaletta Bio?
Cabaletta Bio's fiscal year ends in December.
Where is Cabaletta Bio based?
Cabaletta Bio's address is: 2929 Arch Street, Philadelphia, PA, United States, 19104
What is Cabaletta Bio's ISIN number?
Cabaletta Bio's international securities identification number is: US12674W1099
What is Cabaletta Bio's CUSIP number?
Cabaletta Bio's Committee on Uniform Securities Identification Procedures number is: 12674W109

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site